Carrum Health’s collaboration with Florida Cancer Specialists & Research Institute facilitates a paradigm shift in breast cancer care accessibility. This union grants non-metastatic breast cancer patients associated with Carrum Health-linked employers a substantial two-year treatment coverage plan across almost 100 FCS locations. The initiative includes a comprehensive range of services crucial for treatment, such as radiation, symptom management, and chemotherapy. Moreover, Carrum’s dedication to fostering strategic partnerships and involvement in initiatives like CancerX underscores its commitment to advancing cancer care. This collaboration emphasizes a patient-centric approach, ensuring patients receive comprehensive care, innovative treatments, and convenient access to high-quality services.
Carrum Health, a digital healthcare marketplace catering to employers for bundled healthcare services, has recently collaborated with Florida Cancer Specialists & Research Institute (FCS) to extend breast cancer care services to employers in Florida. This partnership is designed to offer a comprehensive two-year treatment coverage plan to non-metastatic breast cancer patients affiliated with Carrum Health.
The primary focus of Carrum Health is on value-based platforms, empowering self-funded employers to procure specialized care, particularly in surgical and cancer treatments. Through their digital interface, patients gain access to dedicated care specialists who assist them throughout the surgical process. Concurrently, employers are provided with a platform to efficiently navigate Carrum’s network, ensuring seamless access to quality healthcare services.
A cornerstone of Carrum Health’s operations is its Center of Excellence network, which spotlights top-tier surgical centers across the United States, facilitating patients and employers in accessing high-quality care facilities.
Under this collaborative initiative, non-metastatic breast cancer patients associated with Carrum Health-linked employers can avail themselves of an extensive range of breast cancer treatments for two years. These treatments encompass a wide spectrum of services including radiation, symptom management, and chemotherapy, and will be accessible at nearly 100 FCS locations.
Dr. Lucio N. Gordan, President and Managing Physician at FCS, emphasized the unique patient-centric experience provided within a community oncology setting. He highlighted the proximity of resources and advanced treatment options available to patients, emphasizing FCS’s commitment to offering exceptional care through innovations like biosimilar drugs, advanced genetic testing capabilities, and access to clinical trials.
In a broader context, Carrum Health has been actively engaged in strategic partnerships and initiatives to enhance healthcare provisions. In 2021, the company partnered with digital musculoskeletal care entity, Hinge Health, amalgamating Hinge’s digital MSK clinic with Carrum’s Center of Excellence platform to create a comprehensive musculoskeletal offering.
Having secured substantial funding, including a $45 million Series B funding round in May and a $40 million Series A round two years prior, Carrum Health has established a robust financial foundation. The company has also integrated itself into employee-centric care navigation systems and pharmacy benefit programs, such as RightwayHub, underscoring its commitment to holistic healthcare solutions.
Furthermore, Carrum Health’s involvement in initiatives like the White House-led Cancer Moonshot CancerX initiative signifies its dedication to advancing cancer care innovation. This collaboration as part of the CancerX membership enables Carrum to engage with various stakeholders—ranging from federal agencies, digital health and tech startups, and healthcare providers, to patient advocacy groups—in driving progress towards the common goals of reducing cancer-related mortality rates and enhancing the lives of individuals affected by cancer.
Deirdre Saulet, Carrum Health’s Market Vice President for Oncology, expressed enthusiasm about being part of CancerX, emphasizing the potential for collaboration to bring about meaningful advancements in cancer care. Saulet highlighted the significance of a diverse group of experts coming together to share ideas, perspectives, and innovations aimed at improving cancer care outcomes and experiences for patients.
The partnership between Carrum Health and Florida Cancer Specialists & Research Institute marks a significant milestone in reshaping breast cancer care delivery. By providing two years of specialized treatment coverage to non-metastatic breast cancer patients, this collaboration redefines accessibility and quality in healthcare services. Carrum Health’s dedication to value-based care and strategic partnerships amplifies the reach of comprehensive treatment options while prioritizing patient-centric experiences. The initiative not only offers advanced treatments and proximity to care but also embodies a collective commitment to driving innovation in cancer care. Through collaborative efforts and an unwavering focus on patient well-being, this partnership sets a promising precedent for accessible and transformative breast cancer care.
